Vilties vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 171,848 | 192,889 | 164,577 | 164,941 | 246,887 | 231,520 | 198,406 | 203,252 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 5,059 | 12,575 | 10,044 | 20,415 | 2,084 | -16,497 | -29,367 | -9,680 |
| Equity | 49,279 | 61,854 | 71,898 | 92,313 | 94,397 | 77,901 | 48,534 | 38,853 |
| Liabilities | 33,857 | 29,149 | 23,869 | 26,254 | 34,817 | 24,856 | 42,151 | 42,331 |
| Non-current assets | 8,426 | 9,908 | 8,944 | 8,418 | 7,583 | 7,219 | 7,007 | 6,825 |
| Current assets | 73,672 | 79,871 | 85,408 | 108,545 | 119,461 | 93,177 | 81,126 | 71,590 |
| Total assets | 82,098 | 89,779 | 94,352 | 116,963 | 127,044 | 100,396 | 88,133 | 78,415 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 22,219 | 26,653 | 32,896 |
| Social insurance contributions | - | - | - | - | - | 24,516 | 23,240 | 23,864 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.6% | +12.2% | -14.7% | +0.2% | +49.7% | -6.2% | -14.3% | +2.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.2% | 14.0% | 10.6% | 17.5% | 1.6% | -16.4% | -33.3% | -12.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.3% | 20.3% | 14.0% | 22.1% | 2.2% | -21.2% | -60.5% | -24.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.9% | 6.5% | 6.1% | 12.4% | 0.8% | -7.1% | -14.8% | -4.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.5 | 0.3 | 0.3 | 0.4 | 0.3 | 0.9 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 15,163 | 16,186 | 14,311 | 16,358 | 21,625 | 20,428 | 17,506 | 22,376 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vilties vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-09-16 | 2022-10-11 | 1.14 |
| 2022-08-23 | 2022-09-11 | 1.14 |
| 2022-07-25 | 2022-08-09 | 1.14 |
| 2022-06-16 | 2022-07-03 | 200.00 |
Vilties vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vilties vaistine, UAB (code 133772512) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €203.3K, up 2.4% year on year, after €198.4K in 2024 and €231.5K in 2023, showing a decline from the 2023 level but a modest recovery in the latest year. Profitability remained negative throughout the period, although the loss narrowed in 2025 to €9.7K from €29.4K in 2024 and €16.5K in 2023. The 2025 net profit margin was -4.8%, an improvement from -14.8% in 2024. At year-end 2025, total assets were €78.4K, equity €38.9K and liabilities €42.3K. Equity declined from €77.9K in 2023, while liabilities rose from €24.9K in 2023 to above €42K in both 2024 and 2025. Key ratios for 2025 show ROE of -24.9%, ROA of -12.3%, debt to equity of 1.09 and asset turnover of 2.59x. Revenue per employee was €22.6K, with a profit per employee of -€1.1K.